FDA Reinstates Top Vaccines Regulator Days After Abrupt Departure
FDA reinstates top vaccines regulator ten days after abrupt departure, drawing criticism from public health experts and far-right commentators. Departure was tied to Duchenne muscular dystrophy treatment and COVID-19 vaccine controversies.
The FDA reinstated its top vaccines regulator just ten days after his abrupt departure. The regulator serves as director of the Center for Biologics Evaluation and Research at the FDA.
The departure was reportedly linked to controversies surrounding the agency's handling of a treatment for Duchenne muscular dystrophy. His return has drawn criticism from public health experts and far-right commentators, highlighting ongoing tensions regarding the FDA's decisions under the Trump administration, particularly related to COVID-19 vaccine usage.